United Kingdom
-
Friday Five: EnAcuity, Filics, Gallion Health, ODOS, Plasma Fresh
Software that turns surgical cameras into hyperpectral imaging tools, a platform that helps farmers operate more sustainably, and cold plasma that kills foodborne pathogens are all becoming real applications thanks to these spinouts.
-
Brian McCaul steps down as chief executive of QUBIS
Brian McCaul will leave his role at QUBIS, the commercialisation arm of Queen’s University Belfast, at the end of this year after more a decade in charge.
-
Simon Bond moves to the University of Bath
Simon Bond, currently the director of Bristol Innovations, will oversee the development of the Bath Riverside Innovation Quarter.
-
Friday Five: DigitalCNC, Draig Therapeutics, LastingAsset, RIFT, ScopeBio
We take a look at some of the early-stage spinouts that caught our eye. This time: DigitalCNC, Draig Therapeutics, LastingAsset, RIFT, and ScopeBio.
-
Northern Gritstone and Parkwalk Advisors team up for the Northern Universities Venture Fund
Parkwalk Advisors, which already has more than £500 million under management, will manage a new fund in partnership with Northern Gritstone.
-
Friday Five: Astratus, Hirundo, Lembas, OrisDX, and Somnee
We take a look at some of the early-stage spinouts that caught our eye. This time: Astratus, Hirundo, Lembas, OrisDX and Somnee.
-
SETsquared Bristol promotes Caroline Thompson to centre manager
Caroline Thompson had been a programme manager at the SETsquared Partnership since last year and brings more than a decade of experience to her new role.
-
Panel: What’s next for quantum technologies?
What does the future hold for quantum technologies? A panel of experts tackled the challenges at a recent Foresight Live event.
-
Nicky Dibben: People buy products, not technology
Nicky Dibben discusses how marketing strategy is everything that comes between you and your customer, and not simply “fluffy” social media.
-
Winsome Cheung: Startups, here’s what to know when negotiating with big pharma
Winsome Cheung is a partner at Covington who helps biotech startups and big pharma negotiate deals. Here, she shares what to look out for in contracts.
-
Stuart Wilkinson: What does a sweet shop have to do with spinouts?
The impact of university research commercialisation can go far beyond the initial spinout, says Knowledge Exchange UK’s chief executive Stuart Wilkinson.